News

Eli Lilly CEO says company can help 'respond' to national security concerns around essential drugs as tariffs loom
Ricks said reshoring manufacturing capacity for older essential medicines is "a valid thing," adding that Eli Lilly is "happy ...
Fierce Pharma16h
Lilly CEO urges Trump admin to 'level the playing field' by negotiating trade deals, striking down tariffs
As multiple large drugmakers look to navigate trade turbulence by pumping billions of dollars into their U.S. | Eli Lilly CEO ...
Why Eli Lilly Stock Is Sinking Today
Shares of Eli Lilly ( LLY -10.79%) are sliding on Thursday. The stock lost 8.3% as of 12:21 p.m. ET. The leg down comes as ...
Eli Lilly’s worst day in nearly 17 years: Strategist Jared Holz on Q1 results
Jared Holz, Mizuho Securities health care strategist, joins 'Fast Money' to discuss Eli Lilly's biggest day drop since 2008 ...
STAT14h
Assessing the impact of Trump’s first 100 days on science and health policy
STAT editors and reporters review the widespread impact of grant cuts, layoffs and policy changes — and also discuss recent ...
Eli Lilly’s Earnings Report Will Bring a Focus on Tariffs, Not Profits
Eli Lilly, virtually alone among its large-cap pharma peers, has been having an excellent year. The stock is up by a ...
Lilly star weight-loss drug Zepbound faces coverage challenge from CVS Health
Eli Lilly’s stock wobbled Thursday after a looming coverage hit was detailed for its blockbuster weight-loss drug Zepbound.
Jim Cramer on Eli Lilly and Company (LLY): “Riding the wave of GLP-1 success” – Ready to Rebound After a Rare Miss
We recently published a list of Jim Cramer’s Game Plan for This Week: 16 Stocks in Focus. In this article, we are going to ...